EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Intranasal Vaccine Adjuvants and Delivery Platforms: From Barrier Mechanisms to Clinical Translation

Shunyu Yao, Zhe Zhai, Liqi Liao, Linglin Zhong, Chenyu Shi, Yong-Xian Cheng iD, Xuhan Liu iD

Vaccines · 26.03.2026 · 14 (4) · 295

DOI: 10.3390/vaccines14040295 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 26.03.2026. Verfasst von Shunyu Yao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Shenzhen Medical Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a non-invasive mucosal immunization strategy, intranasal vaccines are highly promising for preventing respiratory infectious diseases. Among them, recombinant subunit vaccines represent a safe and ideal option, as they induce targeted mucosal immunity without the safety risks associated with live-vectored or nucleic acid vaccines. However, nasal mucosal defenses rapidly clear antigens before immune activation, limiting protective efficacy. Therefore, intranasal vaccine adjuvants—key regulators of immune response intensity, duration, and type—are essential to overcome mucosal tolerance and improve immunogenicity. Based on a systematic search and analysis of 127 peer-reviewed articles (2010–2026) in PubMed, Web of Science, and Embase, this study comprehensively summarizes the mechanisms, applications, and limitations of existing and candidate adjuvants for intranasal vaccines. This review systematically categorizes and discusses the nasal mucosal barrier, major adjuvant types (e.g., pattern recognition receptor agonists, cytokine adjuvants, and carrier adjuvants), and their mechanisms of action. It also identifies key bottlenecks: insufficient mucosal targeting, inconsistent global safety evaluation standards for adjuvants, and interference from pre-existing antibodies in humans. Furthermore, this review highlights future development directions, including biomimetic adjuvants, pH-responsive nanoadjuvants, and thermostable vaccine formulations. This systematic review clarifies key scientific and technical barriers in intranasal vaccine adjuvant development. The findings provide valuable references for advancing the translation of intranasal vaccines from emergency countermeasures to routine, accessible preventive tools for respiratory infectious diseases.

Schlagwörter

Stichwörter der Autor:innen

adjuvantclinical translationintranasal vaccinemucosal immunityvaccine carrier

Autor:innen und Institutionen

  • School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
  • Guangdong Provincial Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics, Institute for Inheritance-Based Innovation of Chinese Medicine, Marshall Laboratory of Biomedical Engineering, School of Pharmacy…
  • College of Basic Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.

ORCID-Profile: Yong-Xian Cheng, Xuhan Liu

Förderung

  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Shenzhen Medical Research Fund
  • Shenzhen Science and Technology Program
  • National Natural Science Foundation of China https://ror.org/01h0zpd94

Zitieren

APA

Yao, S., Zhai, Z., Liao, L., Zhong, L., Shi, C., Cheng, Y. X., & Liu, X. (2026). Intranasal Vaccine Adjuvants and Delivery Platforms: From Barrier Mechanisms to Clinical Translation. Vaccines, 14(4), 295. https://doi.org/10.3390/vaccines14040295

Vancouver

Yao S, Zhai Z, Liao L, Zhong L, Shi C, Cheng YX, et al. Intranasal Vaccine Adjuvants and Delivery Platforms: From Barrier Mechanisms to Clinical Translation. Vaccines. 2026;14(4):295. doi:10.3390/vaccines14040295

BibTeX
@article{Yao2026,
  author = {Yao, Shunyu and Zhai, Zhe and Liao, Liqi and Zhong, Linglin and Shi, Chenyu and Cheng, Yong-Xian and Liu, Xuhan},
  title = {Intranasal Vaccine Adjuvants and Delivery Platforms: From Barrier Mechanisms to Clinical Translation},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {295},
  doi = {10.3390/vaccines14040295}
}
Kostenlos starten →